Publications by authors named "Mayuko Wada"

Claim this Profile
D
Diazo-Transfer Reaction of Nonactivated Ketones with 2-Azido-1,3-bis(2,6-diisopropylphenyl)imidazolium Hexafluorophosphate (IPrAP).
Mitsuru Kitamura, Kazuki Ohtsuka, Takashi Eto, Masato Tsuzaki, Mayuko Wada

J Org Chem· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psoriasis vulgaris complicated by eosinophilic pneumonia during ustekinumab treatment.
Mika Yashiro, Hideki Maejima, Tomonori Taniguchi, Kensei Katsuoka, Michiko Kimura, Mayuko Wada

Eur J Dermatol· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I and pharmacokinetic study of erlotinib administered in combination with amrubicin in patients with previously treated, advanced non-small cell lung cancer.
Sakiko Otani, Akinobu Hamada, Jiichiro Sasaki, Mayuko Wada, Michiko Yamamoto

Am J Clin Oncol· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Closed reduction of slipped capital femoral epiphysis: high-risk factor for avascular necrosis.
Toshio Kitano, Keisuke Nakagawa, Mayuko Wada, Michiko Moriyama

J Pediatr Orthop B· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pemetrexed for previously treated patients with non-small cell lung cancer and differences in efficacy according to thymidylate synthase expression.
Satoshi Igawa, Shinichiro Ryuge, Mayuko Wada, Sakiko Otani, Sachiyo Maki

Chemotherapy· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I trial of irinotecan and amrubicin with granulocyte colony-stimulating factor support in extensive-stage small-cell lung cancer.
Maiko Asakuma, Michiko Yamamoto, Mayuko Wada, Shinichiro Ryuge, Ken Katono

Cancer Chemother Pharmacol· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I results of vinorelbine with concurrent radiotherapy in elderly patients with unresectable, locally advanced non-small-cell lung cancer: West Japan Thoracic Oncology Group (WJTOG3005-DI).
Hideyuki Harada, Takashi Seto, Satoshi Igawa, Asuka Tsuya, Mayuko Wada

Int J Radiat Oncol Biol Phys· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[A long-term case of Sjögren's syndrome with pulmonary multiple cystic lesions].
Michiko Yamamoto, Masaru Kubota, Yujiro Nagashima, Ken Katono, Mayuko Wada

Nihon Kokyuki Gakkai Zasshi· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Growth of the ulna after repeated bone lengthening in radial longitudinal deficiency.
Kiyoshi Yoshida, Hidehiko Kawabata, Mayuko Wada

J Pediatr Orthop· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New treatment method for developmental dysplasia of the hips after walking age: arthroscopic reduction with limboplasty based on the findings of preoperative imaging.
Toshio Kitano, Yuuki Imai, Mitsuaki Morita, Keisuke Nakagawa, Mayuko Wada

J Orthop Sci· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term disease-free survivor of metastatic large-cell neuroendocrine carcinoma of the lung treated with amrubicin and irinotecan.
Shinichiro Ryuge, Shi-Xu Jiang, Mayuko Wada, Ken Katono, Maiko Iwasaki

Drug Des Devel Ther· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of gefitinib on warfarin antithrombotic activity.
Susumu Arai, Hisashi Mitsufuji, Yasuto Nishii, Sayaka Onoda, Shinichiro Ryuge, Mayuko Wada

Int J Clin Oncol· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolism of irinotecan and its active metabolite SN-38 by intestinal microflora in rats.
Michiko Yamamoto, Akinobu Kurita, Takashi Asahara, Akira Takakura, Ken Katono, Mayuko Wada

Oncol Rep· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I and pharmacologic study of irinotecan and amrubicin in advanced non-small cell lung cancer.
Tomoko Yanaihara, Masanori Yokoba, Sayaka Onoda, Michiko Yamamoto, Shinichiro Ryuge, Mayuko Wada

Cancer Chemother Pharmacol· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis